Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

An anti-inflammatory diet may be beneficial for colon cancer survivors, according to a new clinical trial. People who adhered ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.